Table 3.
PPRV N antigen seroconversion.
| Group | D0a | D42b | D2PCc | D4PCc | D7PCc | D14PCc |
|---|---|---|---|---|---|---|
| PBS | – | – | – | + | + | + |
| – | – | – | + | + | + | |
| – | – | – | + | + | + | |
| – | – | – | + | + | + | |
| – | – | – | + | + | + | |
| Control | – | – | – | + | + | + |
| – | – | – | + | + | + | |
| – | – | – | + | + | + | |
| – | – | – | +/- | + | + | |
| – | – | + | + | + | ||
| Vaccinated | – | – | – | +/- | + | |
| – | – | – | – | +/- | + | |
| – | – | – | – | +/- | + | |
| – | – | – | – | +/- | + |
Sera obtained from anon-vaccinated sheep at day 0, bsheep at 21 days post boost (42 days post first immunization) or from cPPRV challenged animals at the indicated days. Following manufacturers protocols:
+: Anti-N Positive samples.
+/-: Anti-N Doubtful samples.
-: Anti-N Negative samples.